Table 4.
Acute Toxicity Details.
HDR-BT Upfront (n = 58) |
IMRT Upfront (n = 57) |
|||||||
---|---|---|---|---|---|---|---|---|
G1 | G2 | G3 | G4/5 | G1 | G2 | G3 | G4/5 | |
GU | ||||||||
Frequency | 32 (65.5%) | 9 (10.3%) | 0 | 0 | 32 (56.1%) | 12 (21.1%) | 0 | 0 |
Urgency | 27 (46.5%) | 5 (8.6%) | 0 | 0 | 36 (63.2%) | 3 (5.3%) | 0 | 0 |
Dysuria | 26 (44.8%) | 0 | 0 | 0 | 28 (49.1%) | 0 | 0 | 0 |
Obstruction | 22 (37.9%) | 18 (31.0%) | 1 (1.7%) | 0 | 24 (42.1%) | 19 (33.3%) | 0 | 0 |
Incontinence | 3 (5.2%) | 1 (1.7%) | 0 | 0 | 10 (17.5%) | 2 (3.5%) | 0 | 0 |
Hematuria | 24 (41.4%) | 1 (1.7%) | 1 (1.7%) | 0 | 31 (54.4%) | 1 (1.8%) | 0 | 0 |
Temporary Catheter Placement Required |
0 | 4 (6.9%) | 1 (1.7%) | 0 | 0 | 3 (5.3%) | 0 | 0 |
GI | ||||||||
Diarrhea | 28 (50.9%) | 0 | 1 (1.7%) | 0 | 17 (29.8%) | 2 (3.5%) | 0 | 0 |
Rectal Pain | 8 (13.8%) | 0 | 0 | 0 | 25 (43.9%) | 0 | 0 | 0 |
Proctitis | 7 (12.1%) | 5 (8.6%) | 0 | 0 | 14 (24.6%) | 4 (7.0%) | 0 | 0 |